Atlas Trials

Phase 2

89,854 clinical trials · Phase

Sort:Newest firstOldest first

◉ Watch Phase 2

RecordFirmDate
Comparative Study of Techniques in Melanocyte-Keratinocyte Transplantation for the Treatment of Vitiligo (NCT01822379)Henry Ford Health System2010-05-01
The Effects of Atorvastatin on the Nitric Oxide-system in Healthy Young Man (NCT01214746)Regional Hospital Holstebro2010-05-01
Randomised Study Comparing the Effects of Inhaled FF/GW642444M Combination, FF and GW642444M on an Allergen Induced Asthmatic Response (NCT01128595)GlaxoSmithKline2010-05-01
Online Support Groups for Depression and Anxiety (NCT01149265)University College, London2010-05-01
Comparing PET-CT Using C-11 Choline and 18F-Fluoromethylcholine in Patients With Metastatic Prostate Cancer (NCT01132599)Cancer Research UK2010-05-01
Autologous Bone Marrow Derived Stem Cells in Decompensate Cirrhotic Patients (NCT01120925)Royan Institute2010-05-01
A Study of Aleglitazar in Type 2 Diabetes Patients With Moderate Renal Impairment (NCT01043029)Hoffmann-La Roche2010-05-01
Safety of PCI-32765 in Chronic Lymphocytic Leukemia (NCT01105247)Pharmacyclics LLC.2010-05-01
Efficacy of a Multi-strain Probiotic in the Treatment of Irritable Bowel Syndrome (IBS) (NCT01176227)The Canadian College of Naturopathic Medicine2010-05-01
Study With Rituximab, Cyclophosphamide, Doxorubicin Liposomal (Myocet®), Vincristine, Prednisone, (R-COMP) to Treat Non-Hodgkin's Lymphoma (NCT01009970)Fondazione Italiana Linfomi - ETS2010-05-01
A Study Characterizing Pharmacodynamic Profiles in Subjects With Chronic Obstructive Pulmonary Disease (NCT01113593)Dey2010-05-01
Open-label Pilot Study of Lenalidomide (Revlimid) as Adjuvant Treatment for Refractory Cutaneous T Cell Lymphoma (NCT01132989)Florida Academic Dermatology Centers2010-05-01
A Phase 2 Study of Trastuzumab in Combination With TS-ONE and Cisplatin in Firstline Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Advanced Gastric Cancer (NCT01736410)National Cancer Centre, Singapore2010-05-01
A Randomized, Double-masked, Multicenter, Controlled Study of Intravitreal KH902 in Patients With Neovascular AMD (NCT01157715)Chengdu Kanghong Biotech Co., Ltd.2010-05-01
Methylnaltrexone vs Erythromycin for Facilitating Gastric Emptying Time in Critically Ill Patients (NCT01117376)Shiraz University of Medical Sciences2010-05-01
Evaluation of Ridge Dimensional Changes After Immediate Implantation and Efficacy of This Procedure (NCT01399775)Mashhad University of Medical Sciences2010-05-01
Study of Huperzine A Sustained-Release Tablets in Patients With Alzheimer's Disease (NCT01282619)Shandong Luye Pharmaceutical Co., Ltd.2010-05-01
Treatment of Chemotherapy-induced Nausea and Vomiting (NCT01101529)Uppsala University Hospital2010-05-01
MIld to MOderate Acute Pancreatitis: Early naSogastric Tube Feeding Compared With pAncreas Rest (MIMOSA) (NCT01128478)University of Auckland, New Zealand2010-05-01
Chemoradiation Plus Weekly c225 Against Locoregionally Advanced Nasopharyngeal Carcinoma (NPC) (NCT01712919)Jiangsu Cancer Institute & Hospital2010-05-01
Rapid Gastric and Pancreas Cancer Staging Utilizing Peritoneal Lavage (NCT01132755)Memorial Sloan Kettering Cancer Center2010-05-01
Compound Herbal Formula (TPE-1) for Leukopenia and Cancer-related Fatigue in Breast Cancer Patients With Radiotherapy (NCT01142479)Taipei City Hospital2010-05-01
Mensenchymal Stem Cell (MSC) Included in OrthADAPT Membrane for Rotator Cuff Tears Repair (NCT01687777)Hospital San Carlos, Madrid2010-05-01
The Accuracy of Sentinel Node Biopsy of Breast Cancer With Sonographic Abnormal Axillary Lymph Nodes (NCT02005926)Tao OUYANG2010-05-01
A Study Examining the Effects of Nebivolol Compared to Atenolol on Endothelial Function (NCT01522950)University of Minnesota2010-05-01
Predicting Cell Death by Radiation Therapy in Early Stage Non-small Cell Lung Cancer: a Prospective Translational Trial (NCT01138722)University Hospital, Ghent2010-05-01
Behavioral Study to Control Blood Pressure (NCT01035554)Milton S. Hershey Medical Center2010-05-01
Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells (NCT01183728)Red de Terapia Celular2010-05-01
A Proof of Concept Study Comparing Three Doses of an Oral Solution of LEO 22811 With a Placebo Oral Solution for the Treatment of Psoriasis Vulgaris (NCT01116895)LEO Pharma2010-05-01
Study of First-line Single-agent Panitumumab in Frail Elderly Patients With Advanced Wild Type K-RAS Colorectal Cancer (NCT01126112)Spanish Cooperative Group for the Treatment of Digestive Tumours (TTD)2010-05-01
Safety Study of Two Repeat Doses of RT001 for the Treatment of Moderate to Severe Lateral Canthal Lines in Adults (NCT01124565)Revance Therapeutics, Inc.2010-05-01
Safety and Efficacy Study of WRSS1, a Shigella Sonnei Vaccine Candidate (NCT01080716)U.S. Army Medical Research and Development Command2010-05-01
Safety and Efficacy Study of a Non-antibiotic Treatment for the Eradication of Helicobacter Pylori (NCT01109381)Synergy Pharmaceuticals Pte. Ltd.2010-05-01
Study of Mini-Chop Plus Ofatumumab To Treat Cd 20+ Diffuse Large B-Cell Lymphoma In Patients Aged Over 80 Years (NCT01195714)The Lymphoma Academic Research Organisation2010-05-01
Pilot Study for Palliation of Pain in Bone Metastases by MR-HIFU (NCT01117246)Philips Healthcare2010-05-01
A Study in Schizophrenic Patients (NCT01125358)Denovo Biopharma LLC2010-05-01
Clinical Study to Evaluate Antihyperlipidemic Effect of a Classical Unani Antiobesity Formulation (NCT01332747)Jamia Hamdard University2010-05-01
Panitumumab Plus Gemcitabine and Oxaliplatin (GEMOX)Versus GEMOX Alone to Treat Advanced Biliary Tract Adenocarcinoma (NCT01389414)Prof. Massimo Aglietta2010-05-01
A Pilot Study to Evaluate the Role of High-dose Ranibizumab (2.0mg) in the Management of AMD in Patients With Persistent/Recurrent Macular Fluid Less Than 30 Days Following Treatment With Intravitreal Anti-VEGF Therapy (the LAST Study) (NCT01115556)Vitreous -Retina- Macula Consultants of New York2010-05-01
Intracavernous Bone Marrow Stem-cell Injection for Post Prostatectomy Erectile Dysfunction (NCT01089387)Institut National de la Santé Et de la Recherche Médicale, France2010-05-01
Efficacy of Agomelatine in Patients With Obsessive-Compulsive Disorder (NCT01108393)Institut de Recherches Internationales Servier2010-05-01
Clinical Study to Investigate the Pharmacokinetics, Efficacy, Safety and Immunogenicity of a Recombinant FVIII in Patients With Severe Hemophilia A (NCT00989196)Octapharma2010-05-01
Pixantrone Dimaleate in Treating Patients With HER2-Negative Metastatic Breast Cancer (NCT01086605)Alliance for Clinical Trials in Oncology2010-05-01
Japan Dose Regimen Study of AZD1656 in Japanese Type 2 Diabetes Mellitus Patients (NCT01152385)AstraZeneca2010-05-01
TBE-vaccine to Patients With Rheumatoid Arthritis Who Are Using Immunosuppressive Drugs (NCT01131910)Sormland County Council, Sweden2010-05-01
Effect Of Different Lining Materials in Stepwise Excavation (NCT01730287)Azad University of Medical Sciences2010-05-01
Safety and Efficacy Study of Dose-escalated Hypofractionated Radiotherapy For Prostate Cancer (NCT01146340)Sunnybrook Health Sciences Centre2010-05-01
Donor Stem Cell Transplant in Treating Patients With High-Risk Hematologic Malignancies (NCT01341301)Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University2010-05-01
A Dose-Escalation Study Designed to Evaluate the Tolerability, Safety, Pharmacokinetics (PK), and Efficacy of Chronic Topical Ocular Application of INO-8875 in Adults With Ocular Hypertension or Primary Open-Angle Glaucoma (NCT01123785)Inotek Pharmaceuticals Corporation2010-05-01
Comparison of Intravenous Cefazolin Plus Oral Probenecid With Oral Cephalexin for the Treatment of Cellulitis (NCT01029782)Kelowna General Hospital2010-05-01
Open-Label Study of Lenalidomide in Combination With Oral Dexamethasone in the Treatment of Previously Untreated, Symptomatic Patients With Chronic Lymphocytic Leukemia (NCT01133743)University Health Network, Toronto2010-05-01
Efficacy and Safety of ARTISS for Flap Adherence in Abdominoplasty (NCT01112735)Baxter Healthcare Corporation2010-05-01
Study of Sleep-maintenance Activity of 3 Doses of SKP-1041 (NCT00878553)Somnus Therapeutics, Inc.2010-05-01
Gemcitabine, Cisplatin, Epirubicin, and Capecitabine in Treating Patients With Stage I-II Resectable Pancreatic Cancer (NCT01150630)IRCCS San Raffaele2010-05-01
Efficacy and Safety of Three Doses of Aclidinium Bromide Compared to Placebo and to an Active Comparator in Chronic Obstructive Pulmonary Disease (COPD) Patients. (NCT01120093)AstraZeneca2010-05-01
BMAC Enhanced Coronary Artery Bypass Grafting (CABG) (NCT01061580)Harvest Technologies2010-05-01
SAR240550 in Combination With Gemcitabine/Cisplatin in Non-small Cell Lung Cancer (NCT01086254)Sanofi2010-05-01
A Study to Evaluate and Compare Injections of Autologous Dermal and Epidermal Cells Into the Balding Scalp of Subjects With Hair Loss (CA-0004669) (NCT01451177)Aderans Research Institute2010-05-01
Maraviroc Plus Darunavir/Ritonavir for Treatment-Naïve Patients Infected With R5-tropic HIV-1 (NCT00993148)Northwestern University2010-05-01
6-week Study Treatment to Evaluate the Safety and Effectiveness of AZD2066 in Patients With Major Depressive Disorder (NCT01145755)AstraZeneca2010-05-01
Raltegravir in Patients With End Stage Liver Disease and in Transplant Recipients (NCT01022476)ANRS, Emerging Infectious Diseases2010-05-01
Primary Hyperparathyroidism (PHPT): Early Effect of Vitamin D (NCT01329666)Columbia University2010-05-01
A Pilot Study to Evaluate the Efficacy and Safety of Neoadjuvant Chemoradiotherapy With Capecitabine, . . . (NCT01130701)University of Massachusetts, Worcester2010-05-01
Temodar (Temozolomide), Bevacizumab, Lithium and Radiation for High Grade Glioma (NCT01105702)NYU Langone Health2010-05-01
Ipilimumab + Temozolomide in Metastatic Melanoma (NCT01119508)M.D. Anderson Cancer Center2010-05-01
Intravitreal Adalimumab in Patients With Choroidal Neovascularization Secondary to Age-related Macular Degeneration (NCT01136252)Hospital Universitari Vall d'Hebron Research Institute2010-05-01
The Biology of Chronic Preconditioning: Genomic and Physiologic Mechanisms of Response (NCT01164618)The Hospital for Sick Children2010-05-01
Study to Evaluate the Efficacy and Safety of Treatment With Bendamustine in Combination With Ofatumumab in Previously Untreated Patients With Indolent B-Cell Non-Hodgkin's Lymphoma (NHL) (NCT01108341)Cephalon2010-05-01
Alkaline Water in Reducing Skin Toxicity in Women With Breast Cancer Undergoing Radiation Therapy (NCT01487954)Case Comprehensive Cancer Center2010-05-01
Efficacy of AC-150 for the Treatment of Allergic Conjunctivitis in the Enviro-CAC™ Model (NCT01134328)Aciex Therapeutics, Inc.2010-05-01
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases (NCT01290536)Nicholas Fidelman, MD2010-05-01
Transconjunctival Needling Revision Versus Medical Treatment (NCT01887223)University of Sao Paulo General Hospital2010-05-01
Safety and Efficacy Study of Umbilical Cord/Placenta-Derived Mesenchymal Stem Cells to Treat Myelodysplastic Syndromes (NCT01129739)Shandong University2010-05-01
Efficacy, Safety, and Tolerability of TC-5619 in Adults With Attention Deficit/Hyperactivity Disorder (ADHD) (NCT01124708)Targacept Inc.2010-05-01
Complete Neoadjuvant Treatment for REctal Cancer (CONTRE) (NCT01363843)William Sikov MD2010-05-01
Study of a DNA Immunotherapy to Treat Melanoma (NCT01138410)Scancell Ltd2010-05-01
Kudzu Treatment for Alcohol Abuse (NCT01596231)Mclean Hospital2010-05-01
Study of the Safety and Biologic Activity of XOMA 052 in Subjects With Type 2 Diabetes Mellitus (NCT01144975)XOMA (US) LLC2010-05-01
Safety and Efficacy of TKI258 in Relapsed or Refractory Multiple Myeloma Patients, Who Are With or Without t(4;14) Chromosomal Translocation (NCT01058434)Novartis Pharmaceuticals2010-05-01
Laquinimod Phase IIa Study in Active Crohn's Disease (NCT00737932)Teva Branded Pharmaceutical Products R&D, Inc.2010-05-01
Study of PVS-10200 for the Treatment of Restenosis in Patients With Peripheral Artery Disease (TRIUMPH) (NCT01099215)Shire2010-04-30
Letrozole and RAD001 With Advanced or Recurrent Endometrial Cancer (NCT01068249)M.D. Anderson Cancer Center2010-04-30
Investigating the Use of Quercetin on Glucose Absorption in Obesity, and Obesity With Type 2 Diabetes (NCT00065676)National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)2010-04-30
Bevacizumab, Irinotecan and Temozolomide for Relapsed or Refractory Neuroblastoma (NCT01114555)Memorial Sloan Kettering Cancer Center2010-04-29
An Open-label Safety Study of Lusutrombopag (S-888711) in Adults With Chronic Immune Thrombocytopenia (ITP) (NCT01129024)Shionogi2010-04-29
Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma (NCT01149850)Jonsson Comprehensive Cancer Center2010-04-28
Lenalidomide and Prednisone in Low and Int-1 Myelodysplastic Syndrome (MDS) Non 5q MDS (NCT01133275)H. Lee Moffitt Cancer Center and Research Institute2010-04-28
Efficacy, Safety, and Tolerability of JNJ-27018966 (Eluxadoline) in the Treatment of Irritable Bowel Syndrome With Diarrhea (NCT01130272)Furiex Pharmaceuticals, Inc2010-04-28
Study of Platelet Derived Growth Factor Receptor (PDGFR) in Recurrent Malignant Gliomas (NCT01140568)David Piccioni, M.D., Ph.D2010-04-21
Boost GVAX Pancreas Vaccine With or Without CY in Patients With Pancreas Cancer (NCT01088789)Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins2010-04-20
BI 671800 in Asthmatic Patients on Inhaled Corticosteroids (NCT01103349)Boehringer Ingelheim2010-04-20
Gene Therapy for Wiskott-Aldrich Syndrome (NCT01515462)Fondazione Telethon2010-04-20
A Safety and Tolerability Study of JNJ-42160443 in Patients With Moderate to Severe, Chronic Knee Pain From Osteoarthritis (NCT01094262)Johnson & Johnson Pharmaceutical Research & Development, L.L.C.2010-04-20
Fludarabine, Bendamustine, and Rituximab (FBR) for Relapsed Chronic Lymphocytic Leukemia (CLL) (NCT01096992)M.D. Anderson Cancer Center2010-04-19
Sunitinib Malate in Treating Patients With Persistent or Recurrent Clear Cell Ovarian Cancer (NCT00979992)National Cancer Institute (NCI)2010-04-19
Eribulin Mesylate Administered in Combination With Gemcitabine Plus Cisplatin Versus Gemcitabine Plus Cisplatin Alone as First-Line Therapy for Locally Advanced or Metastatic Bladder Cancer (NCT01126749)Eisai Inc.2010-04-16
A Clinical Study Using MEDI-551 in Adult Participants With Relapsed or Refractory Advanced B-Cell Malignancies (NCT00983619)MedImmune LLC2010-04-16
Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast Cancer (NCT01091428)Millennium Pharmaceuticals, Inc.2010-04-16
High-Dose Fluconazole for the Treatment of Cryptococcal Meningitis in HIV-Infected Individuals (NCT00885703)National Institute of Allergy and Infectious Diseases (NIAID)2010-04-16
A Safety & Efficacy Study of BGS649 in Women With Refractory Endometriosis (NCT01116440)Mereo BioPharma2010-04-15
← Previous Next →

Track Phase 2 automatically

Every clearance here is in the API, with alerts when new ones post.